Institutional Ownership
Cen Biotech Inc
CUSIP 15130L104Common / Ordinary StockCENBFQ1 2026
13D / 13G Filings
6
Schedule 13D/13G on record
Beneficial Filers
5
Distinct reporting persons
Largest Stake
26.3%
Max % of class reported
Institutional Holders
2
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
6 filings · latest Jun 25, 2021
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Jun 25, 2021 | Tarrabain Alex | 13D/A | 6.5% | 2.78M | SEC |
| 2 | Jun 15, 2021 | Payne Brian | 13D | 5.3% | 2.21M | SEC |
| 3 | Jun 15, 2021 | Chaaban Bahige B. | 13D | 26.3% | 11.00M | SEC |
| 4 | Jun 15, 2021 | Tarrabain Alex | 13D | 4.2% | 1.77M | SEC |
| 5 | Jun 15, 2021 | Byrne Joseph A. | 13D | 3.6% | 1.52M | SEC |
| 6 | Jun 15, 2021 | Boswell Richard | 13D | 14.3% | 6.00M | SEC |
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Massmutual Private Wealth & Trust, Fsb | 1 | $0 |
| 2 | Ascentis Wealth Management, LLC | 35 | $0 |